COMBATING COUNTERFEIT AND SUBSTANDARD PHARMACEUTICAL PROD-UCTS IN KAZAKHSTAN: STRATEGIES AND PREVENTIVE MEASURES

Abstract The article analyzes the problem of counterfeit and substandard pharmaceutical products in the Republic of Kazakhstan, emphasizing the serious threat they pose to public health and the integrity of the healthcare system. The study examines international practices in combating counterfeit medicines and explores the potential application of these strategies within Kazakhstan. Recommendations are proposed for strengthening the regulatory framework, implementing modern tracking technologies, and enhancing international cooperation to effectively address the issue of counterfeit drugs in the country.